Charles Schwab’s Evolus EOLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.68M | Buy |
530,843
+15,327
| +3% | +$90.5K | ﹤0.01% | 2589 |
|
|
2026
Q1 | $2.12M | Sell |
515,516
-1,613
| -0.3% | -$7.82K | ﹤0.01% | 2707 |
|
|
2025
Q4 | $3.44M | Buy |
517,129
+26,826
| +5% | +$182K | ﹤0.01% | 2592 |
|
|
2025
Q3 | $3.01M | Buy |
490,303
+70,535
| +17% | +$550K | ﹤0.01% | 2645 |
|
|
2025
Q2 | $3.87M | Sell |
419,768
-110
| -0% | -$1.13K | ﹤0.01% | 2441 |
|
|
2025
Q1 | $5.05M | Sell |
419,878
-1,603
| -0.4% | -$21K | ﹤0.01% | 2263 |
|
|
2024
Q4 | $4.65M | Buy |
421,481
+2,905
| +0.7% | +$40.9K | ﹤0.01% | 2365 |
|
|
2024
Q3 | $6.78M | Buy |
418,576
+265,635
| +174% | +$3.71M | ﹤0.01% | 2215 |
|
|
2024
Q2 | $1.66M | Buy |
152,941
+42,255
| +38% | +$520K | ﹤0.01% | 2763 |
|
|
2024
Q1 | $1.55M | Sell |
110,686
-4,093
| -4% | -$53.2K | ﹤0.01% | 2666 |
|
|
2023
Q4 | $1.21M | Buy |
114,779
+173
| +0.2% | +$1.55K | ﹤0.01% | 2770 |
|
|
2023
Q3 | $1.05M | Buy |
114,606
+2,666
| +2% | +$23.9K | ﹤0.01% | 2783 |
|
|
2023
Q2 | $814K | Buy |
111,940
+14,004
| +14% | +$121K | ﹤0.01% | 2837 |
|
|
2023
Q1 | $829K | Buy |
97,936
+5,171
| +6% | +$46.8K | ﹤0.01% | 2803 |
|
|
2022
Q4 | $697K | Buy |
92,765
+1,809
| +2% | +$14K | ﹤0.01% | 2901 |
|
|
2022
Q3 | $733K | Sell |
90,956
-354
| -0.4% | -$3.75K | ﹤0.01% | 2891 |
|
|
2022
Q2 | $1.06M | Sell |
91,310
-27,638
| -23% | -$326K | ﹤0.01% | 2770 |
|
|
2022
Q1 | $1.33M | Sell |
118,948
-52,017
| -30% | -$443K | ﹤0.01% | 2766 |
|
|
2021
Q4 | $1.11M | Hold |
170,965
| – | – | ﹤0.01% | 2869 |
|
|
2021
Q3 | $1.3M | Buy |
170,965
+89,311
| +109% | +$924K | ﹤0.01% | 2791 |
|
|
2021
Q2 | $1.03M | Buy |
81,654
+27,546
| +51% | +$303K | ﹤0.01% | 2919 |
|
|
2021
Q1 | $703K | Sell |
54,108
-3,346
| -6% | -$30.8K | ﹤0.01% | 2963 |
|
|
2020
Q4 | $194K | Hold |
57,454
| – | – | ﹤0.01% | 3261 |
|
|
2020
Q3 | $225K | Hold |
57,454
| – | – | ﹤0.01% | 3143 |
|
|
2020
Q2 | $305K | Buy |
57,454
+7,645
| +15% | +$35.2K | ﹤0.01% | 3038 |
|
|
2020
Q1 | $207K | Hold |
49,809
| – | – | ﹤0.01% | 3007 |
|
|
2019
Q4 | $607K | Buy |
49,809
+15,028
| +43% | +$212K | ﹤0.01% | 2749 |
|
|
2019
Q3 | $544K | Buy |
34,781
+8,588
| +33% | +$141K | ﹤0.01% | 2764 |
|
|
2019
Q2 | $383K | Buy |
26,193
+4,215
| +19% | +$83.5K | ﹤0.01% | 2934 |
|
|
2019
Q1 | $497K | Buy |
21,978
+1,652
| +8% | +$35.7K | ﹤0.01% | 2773 |
|
|
2018
Q4 | $242K | Buy |
20,326
+416
| +2% | +$5.93K | ﹤0.01% | 2992 |
|
|
2018
Q3 | $371K | Buy |
19,910
+10,710
| +116% | +$232K | ﹤0.01% | 2941 |
|
|
2018
Q2 | $258K | Buy |
+9,200
| New | +$162K | ﹤0.01% | 3020 |
|
Other funds holding EOLS
NCM
B
FLSM
PA
SCM
Charles Schwab's EOLS Position: Q2 2026 in Review
Charles Schwab increased its Evolus (EOLS) stake by 3% in Q2 2026, buying an estimated $90.5K and bringing the position to 530,843 shares worth $3.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2589.
Charles Schwab first reported a position in EOLS in Q2 2018 and has held it in 33 quarters since. The position peaked at $6.78M in Q3 2024. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.
- Charles Schwab held 530,843 shares of Evolus worth $3.68M as of Q2 2026.
- Charles Schwab bought 15,327 Evolus shares in Q2 2026, an estimated $90.5K.
- Evolus made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2589 holding.
- Charles Schwab first reported a position in Evolus in Q2 2018 and has held it in 33 quarters since.
- Charles Schwab's Evolus position peaked at $6.78M in Q3 2024.
- 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.